Democratizing hedge fund level analysis tools for everyone
Name | Kalbe Farma Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 06-30-25 |
Name | Latest % | A Month Ago % |
---|---|---|
Public < 5% | 38.58 | 38.7 |
Ladang Ira Panen, Pt | 10.47 | 10.47 |
Gira Sole Prima, Pt | 10.29 | 10.29 |
Santa Seha Sanadi, Pt | 10.08 | 10.08 |
Diptanala Bahana, Pt | 9.52 | 9.52 |
Lucasta Murni Cemerlang, Pt | 9.48 | 9.48 |
Bina Arta Charisma, Pt | 8.21 | 8.21 |
Treasury Shares | 3.03 | 2.91 |
Ronny Hadiana | 0.2 | 0.2 |
Santoso Oen | 0.09 | 0.09 |
B. R. Irawati Setiady | 0.05 | 0.05 |
Others | 0.01 | 0.0 |
Mulialie | 0.0 | 0.0 |
Source | 2022 | 2021 |
---|---|---|
Distribution and Logistic | 36.6% | 37.3% |
Nutritionals | 26.2% | 27.1% |
Prescription Pharmaceutical | 25.0% | 21.3% |
Consumer Health | 12.2% | 14.3% |
Others | 0.0% | 0.0% |
Region | 2022 | 2021 |
---|---|---|
Indonesia | 93.8% | 94.2% |
International | 6.2% | 5.8% |
Others | 0.0% | 0.0% |
Valuation | Ratio | Rank |
---|---|---|
P/S | 1.86 | # 12 / 15 |
EV_EBITDA | 11.08 | # 7 / 15 |
PER | 16.05 | # 8 / 15 |
PBV | 2.52 | # 11 / 15 |
DER | 0.22 | # 3 / 15 |
Profitability | Ratio | Rank |
---|---|---|
NPM % | 11.6 | # 3 / 15 |
ROA % | 13.4 | # 3 / 15 |
ROE % | 15.7 | # 5 / 15 |
Year | DPS | Yield [%] |
---|---|---|
2025 | 36.0 | 0.0 |
2024 | 31.0 | 2.3 |
2023 | 38.0 | 2.4 |
2022 | 35.0 | 1.7 |
2021 | 28.0 | 1.7 |
Timeframe | Performance |
---|---|
1W % | -5.6 |
1Mo % | -7.2 |
3Mo % | -7.8 |
1Yr % | -15.9 |
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
KLBF | 16.05 | 66.94 T | 68.47 T | 34,159 B | 5,862 B | 3,950 B |
SIDO | 13.49 | 15.00 T | 14.69 T | 3,657 B | 1,604 B | 1,201 B |
TSPC | 7.31 | 9.97 T | 8.89 T | 13,197 B | 1,807 B | 1,404 B |
SOHO | 16.51 | 8.88 T | 11.01 T | 10,338 B | 711 B | 581 B |
PYFA | -14.31 | 4.94 T | 10.68 T | 2,771 B | -27 B | -426 B |
KAEF | -7.05 | 2.84 T | 14.19 T | 8,673 B | 365 B | -409 B |